Mesalamine Delayed Release Oral Tablet [Asacol]
RxNorm 369848
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 369848 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: mesalamine Delayed Release Oral Tablet [Asacol].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDF
Semantic Branded Drug Form (SBDF):
Mesalamine Delayed Release Oral Tablet [Asacol]
(Atom ID: 6337458)
Patient Education
Mesalamine
Mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) and also to maintain improvement of ulcerative colitis symptoms. Mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
[Learn More]
* Please review the disclaimer below.